GHAPPcast: CSID in Adults: Clinical Pearls & the Patient Journey
GHAPPcast14 Nov 2024

GHAPPcast: CSID in Adults: Clinical Pearls & the Patient Journey

Live from the GHAPP National 2024 Conference, Dr. Dakesh Patel, a gastroenterologist with the GI Alliance of Illinois, joins Kate Scarlata, MPH, RD, a nationally renowned dietitian and bestselling author, and Kaitlin Colella, PA, to discuss congenital sucrase-isomaltase deficiency (CSID), a frequently overlooked digestive disorder. CSID affects the body's ability to break down sugar and starch due to enzyme deficiencies, often leading to misdiagnosis as IBS. Many patients struggle for years with chronic bloating, diarrhea, constipation, and severe abdominal discomfort without realizing the root cause of their symptoms.

In this insightful discussion, the experts explore the science behind CSID and how sucrase-isomaltase deficiency impacts digestion. They break down the common symptoms that mimic IBS, the challenges in diagnosing the condition, and the importance of proper testing, such as the C13 breath test and small bowel biopsy. Insurance barriers often make it difficult for patients to access enzyme replacement therapy, leaving many untreated or mismanaged. The conversation also covers effective dietary strategies, emphasizing how food choices, portion control, and timing influence symptoms. Caitlyn Colella shares her personal journey of living with CSID, highlighting the struggle of being misdiagnosed for years and how she successfully manages her condition through a combination of dietary adjustments and enzyme therapy.

With CSID affecting a significant percentage of adults previously diagnosed with IBS, this discussion sheds light on an under-recognized condition that has a profound impact on gut health. Healthcare providers and patients alike will gain valuable insights into the latest advancements in diagnosis, treatment, and lifestyle management. Watch now to learn how proper diagnosis and treatment can drastically improve quality of life. For more resources, visit the GHAPP website or download the GHAPP ACE app.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(161)

GHAPPcast: Recognizing and Managing Overt Hepatic Encephalopathy

GHAPPcast: Recognizing and Managing Overt Hepatic Encephalopathy

Thank you to Salix for their support on this podcast episode. In this GHAPP podcast, host Christina Hanson, FNP, welcomes Janet Gripshover, DNP, FNP-BC, MBA, for a practical discussion on recognizing ...

18 Aug 48min

FAQ: Counseling Patients on Overt Hepatic Encephalopathy

FAQ: Counseling Patients on Overt Hepatic Encephalopathy

Thank you to Salix for their support on this FAQ video module.In this FAQ video module, Natalie Oliver, PA-C, discusses how healthcare professionals can counsel patients and caregivers about overt hep...

11 Aug 4min

FAQ: Identifying & Diagnosing Overt Hepatic Encephalopathy

FAQ: Identifying & Diagnosing Overt Hepatic Encephalopathy

Thank you to Salix for their support on this FAQ video module. In this FAQ video module, Samantha Ramirez, NP-C, discusses how healthcare professionals can identify and diagnose overt hepatic encephal...

4 Aug 2min

Subgroup Analysis: Differences in Maintenance Dosing For UC and CD

Subgroup Analysis: Differences in Maintenance Dosing For UC and CD

Thank you to Johnson & Johnson for their support on this podcast episode. In this GHAPP podcast, Amy Stewart, NP, of Capital Digestive Care, introduces a practical inflammatory bowel disease discussio...

23 Jul 7min

Medication Review: Efficacy & Safety of Risankizumab in Patients with Moderate to Severely Active UC

Medication Review: Efficacy & Safety of Risankizumab in Patients with Moderate to Severely Active UC

Thank you to AbbVie for their support of this Medication Review Video Module.In this medication review, Melissa Ferrari, PA, and Jennifer Hamilton, MSPAS, PA-C, provide a comprehensive overview of the...

30 Jun 17min

Med Review: SEQUENCE Trial: Risankizumab vs Ustekinumab in Anti-TNF-Refractory Crohn’s Disease

Med Review: SEQUENCE Trial: Risankizumab vs Ustekinumab in Anti-TNF-Refractory Crohn’s Disease

Thank you to AbbVie for their support on this Medication Review Video Module. In this medication review, Sharon Dudley-Brown, CRNP, PhD from Johns Hopkins University and Angelina Collins, MSN, ANP-BC,...

9 Jun 12min

FAQ: QUASAR Long Term Extension Interim Analysis

FAQ: QUASAR Long Term Extension Interim Analysis

Thank you to Johnson & Johnson for their support on this FAQ Video Module. In this educational video, Jamie Brogan, APRN, from Northwestern Medicine, reviews the latest QUASAR long-term extension data...

2 Jun 4min

Medication Review: Guselkumab IV vs SC Formulation

Medication Review: Guselkumab IV vs SC Formulation

Thank you to Johnson & Johnson for their support on this Medication Review Video Module. In this quick educational video, Angelina Collins, NP, from the University of California San Diego Inflammatory...

28 Mai 3min

Populært innen Helse

fastlegen
rss-gukild-johaug
lydartikler-fra-aftenposten
hvordan-har-du-det-mann
psykodrama
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-skravla-gar
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
rss-garne-damer
foreldreradet
morten-ramm-lar-kakla-ga-til-du-sovner
klimaks
g-punktet
hjernesterk
rss-lev-vel
rss-lopedrommen
treningsprat
rss-kunsten-a-leve
kjed-deg-i-sovn-verdens-kjedeligste-podcast